Latest Breaking News On - Jacques bienaime - Page 1 : comparemela.com

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) Director Jean Jacques Bienaime sold 20,000 shares of the business’s stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $81.62, for a total transaction of $1,632,400.00. Following the transaction, the director now owns 474,994 shares in the company, valued […]

Jean jacques bienaimeRobertw bairdPiper sandlerBiomarin pharmaceutical incAvoro capital advisorsCapital research global investorsCanaccord genuity groupAmeriprise financial incMorgan stanleyVanguard group incBiomarin pharmaceutical company profileBarclays plcBiomarin pharmaceuticalGet free reportDirector jean jacques bienaimeJacques bienaime